Log in
Enquire now
Wugen

Wugen

Wugen is an off-the-shelf Cell Therapies for Cancer founded by Matthew Cooper, Todd Fehniger, Melissa Berrien-Elliott and John DiPersio.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
CEO
‌
Daniel S. Kemp
0
Company Operating Status
Active
Country
United States
United States
Founder
‌
Matthew Cooper
0
‌
Melissa Berrien-Elliott
0
‌
John DiPersio
0
‌
Todd Fehniger
0
Industry
‌
CAR T-Cell therapy
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Biotechnology
Biotechnology
Genomics
Genomics
‌
Genome editing
Cell therapy
Cell therapy
Stem cell
Stem cell
Engineering
Engineering
•••
Investors
Intermediate Capital Group
Intermediate Capital Group
0
Abingworth
Abingworth
0
Aisling Capital
Aisling Capital
0
Alexandria Venture Investments
Alexandria Venture Investments
0
Tybourne Capital Management
Tybourne Capital Management
Alpha Wave Global
Alpha Wave Global
0
Latest Funding Round Date
July 16, 2021
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/wugen
Location
St. Louis
St. Louis
0
San Diego
San Diego
Number of Employees
73
0
Number of Employees (Ranges)
51 – 200
0
Pitchbook URL
pitchbook.com/profiles...234811-36
Technologies Used
CRISPR
CRISPR
Total Funding Amount (USD)
172,000,000
Twitter URL
@wugen3
Official Website
wugen.com

Find more companies like Wugen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.